M. Wedin, E. Lindqvist, M. Fredrikson, P. Kjølhede
{"title":"Short commentary on Lymphedema after Treatment for Endometrial Cancer","authors":"M. Wedin, E. Lindqvist, M. Fredrikson, P. Kjølhede","doi":"10.4172/2161-0932.1000442","DOIUrl":null,"url":null,"abstract":"Volume 7 • Issue 6 • 1000442 Gynecol Obstet (Sunnyvale), an open access journal ISSN: 2161-0932 Lymphedema development after cancer treatment in women with endometrial cancer is a poorly explored complication and there is a substantial gap in the knowledge of this troublesome treatmentrelated adverse effect. Endometrial cancer is the most common gynecological cancer. The majority of the women diagnosed with endometrial cancer will be long-term survivors. The primary treatment of endometrial cancer most often comprises hysterectomy and bilateral salpingo-oophorectomy. Pelvic and para-aortic lymphadenectomy is recommended in prognostic high-risk groups of endometrial cancer. Lymphedema development is associated with lymphadenectomy.","PeriodicalId":22164,"journal":{"name":"Surgery, gynecology & obstetrics","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery, gynecology & obstetrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-0932.1000442","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Volume 7 • Issue 6 • 1000442 Gynecol Obstet (Sunnyvale), an open access journal ISSN: 2161-0932 Lymphedema development after cancer treatment in women with endometrial cancer is a poorly explored complication and there is a substantial gap in the knowledge of this troublesome treatmentrelated adverse effect. Endometrial cancer is the most common gynecological cancer. The majority of the women diagnosed with endometrial cancer will be long-term survivors. The primary treatment of endometrial cancer most often comprises hysterectomy and bilateral salpingo-oophorectomy. Pelvic and para-aortic lymphadenectomy is recommended in prognostic high-risk groups of endometrial cancer. Lymphedema development is associated with lymphadenectomy.